Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
#PCR And Realtime PCR Testing Market Forecast: Value Set To Climb From $12.02 Billion To $16.38 Billion#_x000D_
The pcr and realtime pcr testing market size has experienced robust growth in recent years. It is forecast to increase from $11.12 billion in 2025 to $12.02 billion in 2026, at a compound annual growth rate (CAGR) of 8.1%. This historic expansion can be attributed to several factors, including the wider adoption of molecular diagnostics, the rising prevalence of infectious diseases, increased genomics research activities, the growing application of pcr in clinical diagnostics, and the expansion of academic research infrastructure._x000D_
_x000D_
The pcr and realtime pcr testing market is anticipated to experience robust growth over the next few years, reaching $16.38 billion in 2030 at a compound annual growth rate (CAGR) of 8.0%. This projected expansion during the forecast period is driven by factors such as the increasing need for personalized medical treatments, the growing acceptance of digital pcr innovations, the spread of decentralized diagnostic services, increasing capital allocation to life science research, and the expanding application of pcr in cancer diagnosis and genetic analysis. Key developments anticipated during this period involve the greater uptake of high-throughput pcr platforms, a heightened need for multiplex real-time pcr assays, the increased incorporation of automated sample preparation setups, the broadening scope of digital pcr uses, and a stronger emphasis on ensuring contamination-free testing._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#PCR And Realtime PCR Testing Market Growth Drivers: What’s Behind The Acceleration?#_x000D_
The increasing approvals for personalized medicines are anticipated to boost the PCR And real-time PCR testing market moving forward. Personalized medicines are medical interventions or therapies specifically developed for each patient. Their development relies on an individual’s genetic makeup, biomarkers, observable traits, or psychological factors, which help foresee how a patient will react to a specific therapy. Within personalized medicine, PCR and Real-Time PCR technologies allow for the accurate detection of genetic differences, enabling customized treatments that meet individual patient requirements and enhance therapeutic results. A notable example occurred in February 2024, when the Personalised Medicine Coalition, a US-based hospital and health care organization, reported that the FDA gave approval to 16 new personalized treatments for rare disease patients in 2023, a significant increase from six in 2022. Consequently, the growing number of approvals for personalized medicines is a key impetus for the PCR And real-time PCR testing market._x000D_
_x000D_
#PCR And Realtime PCR Testing Market Segment Outlook: Which Categories Are Growing Fastest?#_x000D_
The pcr and realtime pcr testing market covered in this report is segmented – _x000D_
_x000D_
1) By Product: Consumables And Reagents, Instruments, Software And Services_x000D_
2) By Technology: Quantitative PCR, Digital PCR_x000D_
3) By Application: Clinical Diagnostics, Life Science Research, Industrial Applications, Other Applications_x000D_
4) By End-Use: Academic And Research Institutes, Pharmaceutical And Biotechnology, Clinical Diagnostics Labs And Hospitals, Other End Users_x000D_
_x000D_
Subsegments:_x000D_
1) By Consumables And Reagents: PCR Reagents, PCR Kits, PCR Primers And Probes, DNA And RNA Extraction Kits _x000D_
2) By Instruments: PCR Machines/Amplifiers, Real-Time PCR Systems, Thermal Cyclers, Automated PCR Systems _x000D_
3) By Software And Services: Data Analysis Software, PCR Software, Maintenance And Support Services, Training Services_x000D_
_x000D_
#PCR And Realtime PCR Testing Market Trends: What’s Defining The Industry’s Next Phase?#_x000D_
Leading firms within the PCR and real-time PCR testing sector are creating highly specialized detection kits, including variant-targeted RT PCR assays, with the aim of more effectively monitoring viral evolution and bolstering epidemiological surveillance efforts. These variant-targeted RT PCR assays serve as molecular diagnostic tools engineered to identify specific genetic alterations or variations present in a virus, thereby facilitating accurate identification of distinct viral strains or sub-variants. As an example, in January 2023, Roche, a diagnostics company based in Switzerland, launched the VirSNiP SARS CoV 2 Spike F486P assay, which is a real-time PCR test precisely identifying the F486P mutation found in the XBB.1.5 Omicron sub-variant. This particular kit operates on conventional real-time PCR platforms like LightCycler 480 II and cobas z 480, offering researchers accurate lineage differentiation to assist with variant tracking._x000D_
_x000D_
#PCR And Realtime PCR Testing Market Competitive Analysis Of Leading Industry Participants#_x000D_
Major companies operating in the pcr and realtime pcr testing market are Abbott Laboratories, Agilent Technologies Inc., bioMérieux SA, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., QIAGEN N.V., GenMark Diagnostics Inc., Thermo Fisher Scientific Inc., General Electric Company, Danaher Corporation, Becton Dickinson and Company, Luminex Corporation, Meridian Bioscience Inc., Fluidigm Corporation, RainDance Technologies Inc., BioFire Diagnostics LLC, Cepheid Inc., Illumina Inc., Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Promega Corporation, Takara Bio Inc., Twist Bioscience Corporation, Zymo Research Corporation, BioChain Institute Inc., BioLegend Inc., Bioo Scientific Corporation, Creative Diagnostics, Eurofins Scientific SE, Myriad Genetics Inc. _x000D_
_x000D_
#View The Full PCR And Realtime PCR Testing Market Report:#_x000D_
_x000D_
#PCR And Realtime PCR Testing Market Geographic Distribution And Regional Opportunities#_x000D_
Asia-Pacific was the largest region in the PCR and real-time PCR testing market in 2025. Western Europe was the second-largest region in the PCR and real-time PCR testing market. The regions covered in the pcr and realtime pcr testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.